| The nanomechanical signature of breast cancer M Plodinec, M Loparic, CA Monnier, EC Obermann, R Zanetti-Dallenbach, ... Nature nanotechnology 7 (11), 757-765, 2012 | 1106 | 2012 |
| Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis L Bonapace, MM Coissieux, J Wyckoff, KD Mertz, Z Varga, T Junt, ... Nature 515 (7525), 130-133, 2014 | 686 | 2014 |
| NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells M Bentires-Alj, V Barbu, M Fillet, A Chariot, B Relic, N Jacobs, J Gielen, ... Oncogene 22 (1), 90-97, 2003 | 633 | 2003 |
| Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia M Bentires-Alj, JG Paez, FS David, H Keilhack, B Halmos, K Naoki, ... Cancer research 64 (24), 8816-8820, 2004 | 605 | 2004 |
| Glucocorticoids promote breast cancer metastasis MMS Obradović, B Hamelin, N Manevski, JP Couto, A Sethi, ... Nature 567 (7749), 540-544, 2019 | 336 | 2019 |
| Nuclear factor-κB, cancer, and apoptosis V Bours, M Bentires-Alj, AC Hellin, P Viatour, P Robe, S Delhalle, ... Biochemical pharmacology 60 (8), 1085-1089, 2000 | 334 | 2000 |
| Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling A Britschgi, A Bill, H Brinkhaus, C Rothwell, I Clay, S Duss, M Rebhan, ... Proceedings of the National Academy of Sciences 110 (11), E1026-E1034, 2013 | 327 | 2013 |
| PIK3CAH1047R induces multipotency and multi-lineage mammary tumours S Koren, L Reavie, JP Couto, D De Silva, MB Stadler, T Roloff, A Britschgi, ... Nature 525 (7567), 114-118, 2015 | 314 | 2015 |
| Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase T Sun, N Aceto, KL Meerbrey, JD Kessler, C Zhou, I Migliaccio, ... Cell 144 (5), 703-718, 2011 | 314 | 2011 |
| Breast tumor heterogeneity: source of fitness, hurdle for therapy S Koren, M Bentires-Alj Molecular cell 60 (4), 537-546, 2015 | 303 | 2015 |
| Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop N Aceto, N Sausgruber, H Brinkhaus, D Gaidatzis, G Martiny-Baron, ... Nature medicine 18 (4), 529-537, 2012 | 303 | 2012 |
| Mechanism-based cancer therapy: resistance to therapy, therapy for resistance P Ramos, M Bentires-Alj Oncogene 34 (28), 3617-3626, 2015 | 280 | 2015 |
| JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer A Britschgi, R Andraos, H Brinkhaus, I Klebba, V Romanet, U Müller, ... Cancer cell 22 (6), 796-811, 2012 | 271 | 2012 |
| Protein-tyrosine phosphatase 1B is required for HER2/Neu–induced breast cancer M Bentires-Alj, BG Neel Cancer research 67 (6), 2420-2424, 2007 | 270 | 2007 |
| Patient-derived xenograft (PDX) models in basic and translational breast cancer research LE Dobrolecki, SD Airhart, DG Alferez, S Aparicio, F Behbod, ... Cancer and Metastasis Reviews 35, 547-573, 2016 | 252 | 2016 |
| Stops along the RAS pathway in human genetic disease M Bentires-Alj, MI Kontaridis, BG Neel Nature medicine 12 (3), 283-285, 2006 | 246 | 2006 |
| A role for the scaffolding adapter GAB2 in breast cancer M Bentires-Alj, SG Gil, R Chan, ZC Wang, Y Wang, N Imanaka, LN Harris, ... Nature medicine 12 (1), 114-121, 2006 | 245 | 2006 |
| NF-κB2/p100 induces Bcl-2 expression P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L de Leval, ... Leukemia 17 (7), 1349-1356, 2003 | 238 | 2003 |
| VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation A Fantozzi, DC Gruber, L Pisarsky, C Heck, A Kunita, M Yilmaz, ... Cancer research 74 (5), 1566-1575, 2014 | 220 | 2014 |
| Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma C Desmet, P Gosset, B Pajak, D Cataldo, M Bentires-Alj, P Lekeux, ... The Journal of immunology 173 (9), 5766-5775, 2004 | 204 | 2004 |
